Maven Securities’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.27M Buy
+10,300
New +$2.85M 0.04% 230
2025
Q2
Sell
-1,600
Closed -$424K 823
2025
Q1
$424K Sell
1,600
-8,300
-84% -$2.05M 0.01% 627
2024
Q4
$2.3M Sell
9,900
-12,600
-56% -$2.9M 0.06% 260
2024
Q3
$4.96M Buy
22,500
+5,700
+34% +$1.18M 0.1% 180
2024
Q2
$3.3M Buy
+16,800
New +$3.47M 0.07% 268
2024
Q1
Sell
-1,200
Closed -$253K 472
2023
Q4
$253K Sell
1,200
-1,800
-60% -$384K 0.01% 852
2023
Q3
$601K Buy
3,000
+1,000
+50% +$199K 0.01% 765
2023
Q2
$371K Sell
2,000
-2,600
-57% -$480K 0.01% 686
2023
Q1
$881K Hold
4,600
0.02% 500
2022
Q4
$774K Buy
+4,600
New +$799K 0.02% 473
2022
Q2
Sell
-1,500
Closed -$357K 917
2022
Q1
$357K Buy
+1,500
New +$352K 0.01% 645

Other funds holding CME

Maven Securities's CME Position: Q3 2025 in Review

Maven Securities sold out of CME Group (CME) in Q3 2025, closing a stake of 3,918 shares — an estimated $1.08M sold.

Maven Securities first reported a position in CME in Q4 2016 and held it in 32 quarters. The position peaked at $3.78M in Q3 2019. 1,653 funds tracked by Wall St. Rank hold CME as of Q3 2025.

  • Maven Securities reported no remaining CME Group position as of Q3 2025 after selling out during the quarter.
  • Maven Securities sold 3,918 CME Group shares in Q3 2025, an estimated $1.08M.
  • Maven Securities first reported a position in CME Group in Q4 2016 and held it in 32 quarters.
  • Maven Securities's CME Group position peaked at $3.78M in Q3 2019.
  • 1,653 funds tracked by Wall St. Rank held CME Group as of Q3 2025.

Based on Maven Securities's 13F filing for Q3 2025, filed 20 Nov 2025.